Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03931291 |
|---|---|
| Brief Title: | APR-246 in Combination With Azacitidine for TP53 Mutated AML (Acute Myeloid Leukemia) or MDS (Myelodysplastic Syndromes) Following Allogeneic Stem Cell Transplant |
| First Submitted : | April 26, 2019 |
| First Submitted that Met QC Criteria : | April 26, 2019 |
| First Posted : | April 30, 2019 |
| Last Update Submitted that Met QC Criteria : | January 18, 2022 |
| Last Update Posted : | January 19, 2022 |